Top Markets
Coin of the day
GlobeStar Therapeutics Corporation GlobeStar Therapeutics Corporation

GlobeStar Therapeutics Corporation

GSTC
Rang in Aktien #40541
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm... GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-12
Marktkapitalisierung
$124.11K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
9,900.00%
Land
US
Handel GlobeStar Therapeutics Corporation (GSTC)

Kategorie

Kursverlauf für GlobeStar Therapeutics Corporation (GSTC)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $0.52 am 2011-09-01
Kursverlauf der Aktie von GlobeStar Therapeutics Corporation von 2011 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 -78.50%
2024 -75.25%
2023 -91.75%
2022 15.46%
2021 92.64%
2020 100.22%
2019 -81.73%
2018 -35.66%
2017 -80.76%
2016 -46.86%
2015 1,090.09%
2014 285.94%
2013 -62.10%
2012 -95.07%
2011 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE